SEC Form 4 · accession 0001140361-15-009149
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Graham G Miao
Officer — CFO
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | Feb 24, 2015 | A | 147,973 | $1.85 | A | 211,872 | D | |
| Common StockF1 | holding | — | — | — | 63,899 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF2 | $1.79 | holding | — | — | — | — | Oct 20, 2019 | Common Stock | 117,187 | 117,187 | D |
Explanation of responses
- F1Includes 41,899 restricted stock units that vest on October 20, 2017.
- F2Stock appreciation rights that vest one-third on each of 10/20/15, 10/20/16, and 10/20/17.
- F3Restricted shares of common stock that vest on February 24, 2018.